# Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer

> **NCT01628380** · PHASE3 · UNKNOWN · sponsor: **A.O. Ospedale Papa Giovanni XXIII** · enrollment: 94 (estimated)

## Conditions studied

- Ovarian Neoplasms

## Interventions

- **PROCEDURE:** Cytoreductive Surgery and HIPEC
- **PROCEDURE:** CRS alone

## Key facts

- **NCT ID:** NCT01628380
- **Lead sponsor:** A.O. Ospedale Papa Giovanni XXIII
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2018-06
- **Final completion:** 2018-07
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2014-08-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01628380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01628380, "Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01628380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*